Literature DB >> 17227694

Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients.

Niklas Mattsson1, Sara Haghighi, Oluf Andersen, Yuemang Yao, Lars Rosengren, Kaj Blennow, Domenico Praticò, Henrik Zetterberg.   

Abstract

Lipid peroxidation has been implicated in the pathogenesis of multiple sclerosis (MS). Isoprostanes, isomers of prostaglandins, are produced by free radical-mediated peroxidation of fatty acids in vivo and can be quantified in biological fluids. This study examines the levels of cerebrospinal fluid (CSF) F2-isoprostanes (F2-iPs) in MS patients (n=46), their healthy siblings (n=46) and unrelated controls (n=50). The median CSF F2-iP concentration (range) was significantly higher in siblings of MS patients, as compared to healthy controls (40.0 [7.1-68.7] and 29.1 [6.4-60.3] pg/mL, respectively, p=0.031). MS patients demonstrated F2-iP levels intermediate between siblings and controls. F2-iP levels in MS patients and siblings correlated significantly (R=0.360, p=0.012). These results suggest that siblings of MS patients have an increased oxidative stress response to environmental and/or genetic factors that may be involved in MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17227694     DOI: 10.1016/j.neulet.2006.12.044

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Non-aqueous microchip electrophoresis for characterization of lipid biomarkers.

Authors:  Larry R Gibson; Paul W Bohn
Journal:  Interface Focus       Date:  2013-06-06       Impact factor: 3.906

2.  Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.

Authors:  Carmen Martínez; Elena García-Martín; Julián Benito-León; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecilla; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Neuromolecular Med       Date:  2009-10-14       Impact factor: 3.843

Review 3.  Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.

Authors:  Genaro G Ortiz; Fermín P Pacheco-Moisés; Oscar K Bitzer-Quintero; Ana C Ramírez-Anguiano; Luis J Flores-Alvarado; Viridiana Ramírez-Ramírez; Miguel A Macias-Islas; Erandis D Torres-Sánchez
Journal:  Clin Dev Immunol       Date:  2013-09-24

Review 4.  Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases.

Authors:  Elżbieta Miller; Agnieszka Morel; Luciano Saso; Joanna Saluk
Journal:  Oxid Med Cell Longev       Date:  2014-04-29       Impact factor: 6.543

5.  NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.

Authors:  José A G Agúndez; Elena García-Martín; Carmen Martínez; Julián Benito-León; Jorge Millán-Pascual; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecillas; José Francisco Plaza-Nieto; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2014-04-23       Impact factor: 2.474

6.  The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.

Authors:  Gerwyn Morris; Michael Berk
Journal:  BMC Med       Date:  2015-04-01       Impact factor: 8.775

7.  CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.

Authors:  Fozia Mir; Donald Lee; Hetal Ray; Saud A Sadiq
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-08-14

8.  Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.

Authors:  Do Young Kim; Junwei Hao; Ruolan Liu; Gregory Turner; Fu-Dong Shi; Jong M Rho
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

Review 9.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

10.  Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.

Authors:  Magda A Lam; Ghassan J Maghzal; Mohsen Khademi; Fredik Piehl; Rikke Ratzer; Jeppe Romme Christensen; Finn Thorup Sellebjerg; Tomas Olsson; Roland Stocker
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.